Mediator MED23 plays opposing roles in directing smooth muscle cell and adipocyte differentiation

Genes and Development

Volumn 26, Issue 19, 2012, Pages 2192-2205

  Yin, Jing wen ^a   Liang, Yan ^a   Park, Ji Yeon ^b   Chen, Dongrui ^c   Yao, Xiao ^a   Xiao, Qi ^d   Liu, Zhen ^a   Jiang, Bo ^a,e   Fu, Yu ^a   Bao, Menghan ^a   Huang, Yan ^a   Liu, Yuting ^c   Yan, Jun ^c   Zhu, Min sheng ^d   Yang, Zhongzhou ^d   Gao, Pingjin ^c   Tian, Bin ^b   Li, Dangsheng ^c   Wang, Gang ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^d NANJING UNIVERSITY   (China)

^e XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Adipocyte; Differentiation; ELK1; MAL; MED23; Mediator complex; Smooth muscle cell

Indexed keywords

CELL PROTEIN; PROTEIN MED23; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ELK1 GENE; EMBRYO; EMBRYO DEVELOPMENT; GENE; GENE EXPRESSION; MAL GENE; MED23 GENE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; RHOA GENE; SMC GENE; SMOOTH MUSCLE FIBER; ZEBRA FISH;

ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOSKELETON; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HELA CELLS; HUMANS; MEDIATOR COMPLEX; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; ZEBRAFISH;

DANIO RERIO;

EID: 84867185411     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.192666.112     Document Type: Article

References (45)

1. Balamotis MA, Pennella MA, Stevens JL, Wasylyk B, Belmont AS, Berk AJ. 2009. Complexity in transcription control at the activation domain-mediator interface. Sci Signal 2: ra20. doi: 10.1126/scisignal.1164302.
2. Ball SG, Shuttleworth CA, Kielty CM. 2010. Platelet-derived growth factor receptors regulate mesenchymal stem cell fate: Implications for neovascularization. Expert Opin Biol Ther 10: 57-71.
3. Blazek E, Mittler G, Meisterernst M. 2005. The mediator of RNA polymerase II. Chromosoma 113: 399-408.
4. Boyer TG, Martin ME, Lees E, Ricciardi RP, Berk AJ. 1999. Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein. Nature 399: 276-279.
5. Buchwalter G, Gross C, Wasylyk B. 2004. Ets ternary complex transcription factors. Gene 324: 1-14.
6. Cen B, Selvaraj A, Prywes R. 2004. Myocardin/MKL family of SRF coactivators: Key regulators of immediate early and muscle specific gene expression. J Cell Biochem 93: 74-82.
7. Cross LM, Cook MA, Lin S, Chen JN, Rubinstein AL. 2003. Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay. Arterioscler Thromb Vasc Biol 23: 911-912.
8. de Villiers JA, Houreld N, Abrahamse H. 2009. Adipose derived stem cells and smooth muscle cells: Implications for regenerative medicine. Stem Cell Rev 5: 256-265.
9. Ding N, Zhou H, Esteve PO, Chin HG, Kim S, Xu X, Joseph SM, Friez MJ, Schwartz CE, Pradhan S, et al. 2008. Mediator links epigenetic silencing of neuronal gene expression with X-linked mental retardation. Mol Cell 31: 347-359.
10. Ge K, Guermah M, Yuan CX, Ito M, Wallberg AE, Spiegelman BM, Roeder RG. 2002. Transcription coactivator TRAP220 is required for PPARg2-stimulated adipogenesis. Nature 417: 563-567.
11. Gineitis D, Treisman R. 2001. Differential usage of signal transduction pathways defines two types of serum response factor target gene. J Biol Chem 276: 24531-24539.
12. Gupta RK, Mepani RJ, Kleiner S, Lo JC, Khandekar MJ, Cohen P, Frontini A, Bhowmick DC, Ye L, Cinti S, et al. 2012. Zfp423 expression identifies committed preadipocytes and localizes to adipose endothelial and perivascular cells. Cell Metab 15: 230-239.
13. Hashimoto S, Boissel S, Zarhrate M, Rio M, Munnich A, Egly JM, Colleaux L. 2011. MED23 mutation links intellectual disability to dysregulation of immediate early gene expression. Science 333: 1161-1163.
14. Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, Mueller E, Benjamin T, Spiegelman BM, Sharp PA, et al. 2005. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309: 1074-1078.
15. Huang H, Song TJ, Li X, Hu L, He Q, Liu M, Lane MD, Tang QQ. 2009. BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci 106: 12670-12675.
16. Kajimura S, Seale P, Kubota K, Lunsford E, Frangioni JV, Gygi SP, Spiegelman BM. 2009. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-β transcriptional complex. Nature 460: 1154-1158.
17. Kato Y, Habas R, Katsuyama Y, Naar AM, He X. 2002. A component of the ARC/Mediator complex required for TGFb/Nodal signalling. Nature 418: 641-646.
18. Komori T. 2002. [Cbfa1/Runx2, an essential transcription factor for the regulation of osteoblast differentiation]. Nihon Rinsho 60: 91-97.
19. Mack CP, Hinson JS. 2005. Regulation of smooth muscle differentiation by the myocardin family of serum response factor co-factors. J Thromb Haemost 3: 1976-1984.
20. Malik S, Roeder RG. 2010. The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet 11: 761-772.
21. Miano JM. 2003. Serum response factor: Toggling between disparate programs of gene expression. J Mol Cell Cardiol 35: 577-593.
22. Miralles F, Posern G, Zaromytidou AI, Treisman R. 2003. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113: 329-342.
23. Olson EN. 1990. MyoD family: A paradigm for development? Genes Dev 4: 1454-1461.
24. Philippar U, Schratt G, Dieterich C, Muller JM, Galgoczy P, Engel FB, Keating MT, Gertler F, Schule R, Vingron M, et al. 2004. The SRF target gene Fhl2 antagonizes RhoA/MAL- dependent activation of SRF. Mol Cell 16: 867-880.
25. Pinney DF, Emerson CP Jr. 1989. 10T1/2 cells: An in vitro model for molecular genetic analysis of mesodermal determination and differentiation. Environ Health Perspect 80: 221-227.
26. Pipes GC, Creemers EE, Olson EN. 2006. The myocardin family of transcriptional coactivators: Versatile regulators of cell growth, migration, and myogenesis. Genes Dev 20: 1545-1556.
27. Posern G, Treisman R. 2006. Actin' together: Serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol 16: 588-596.
28. Rodeheffer MS, Birsoy K, Friedman JM. 2008. Identification of white adipocyte progenitor cells in vivo. Cell 135: 240-249.
29. Schaffler A, Buchler C. 2007. Concise review: Adipose tissue- derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 25: 818-827.
30. Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, Scime A, Devarakonda S, Conroe HM, Erdjument-Bromage H, et al. 2008. PRDM16 controls a brown fat/skeletal muscle switch. Nature 454: 961-967.
31. Settleman J. 2003. A nuclear MAL-function links Rho to SRF. Mol Cell 11: 1121-1123.
32. Stevens JL, Cantin GT, Wang G, Shevchenko A, Shevchenko A, Berk AJ. 2002. Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit. Science 296: 755-758.
33. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
34. Tang W, Zeve D, Suh JM, Bosnakovski D, Kyba M, Hammer RE, Tallquist MD, Graff JM. 2008. White fat progenitor cells reside in the adipose vasculature. Science 322: 583-586.
35. Tontonoz P, Hu E, Spiegelman BM. 1995. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor g. Curr Opin Genet Dev 5: 571-576.
36. Tran KV, Gealekman O, Frontini A, Zingaretti MC, Morroni M, Giordano A, Smorlesi A, Perugini J, De Matteis R, Sbarbati A, et al. 2012. The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells. Cell Metab 15: 222-229.
37. Van Aelst L, D'Souza-Schorey C. 1997. Rho GTPases and signaling networks. Genes Dev 11: 2295-2322.
38. Vartiainen MK, Guettler S, Larijani B, Treisman R. 2007. Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science 316: 1749-1752.
39. Wang DZ, Olson EN. 2004. Control of smooth muscle development by the myocardin family of transcriptional coactivators. Curr Opin Genet Dev 14: 558-566.
40. Wang Z, Wang DZ, Pipes GC, Olson EN. 2003. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci 100: 7129-7134.
41. Wang Z, Wang DZ, Hockemeyer D, McAnally J, Nordheim A, Olson EN. 2004. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428: 185-189.
42. Wang G, Balamotis MA, Stevens JL, Yamaguchi Y, Handa H, Berk AJ. 2005. Mediator requirement for both recruitment and postrecruitment steps in transcription initiation. Mol Cell 17: 683-694.
43. Wang W, Huang L, Huang Y, Yin JW, Berk AJ, Friedman JM, Wang G. 2009. Mediator MED23 links insulin signaling to the adipogenesis transcription cascade. Dev Cell 16: 764-771.
44. Wernig M, Lengner CJ, Hanna J, Lodato MA, Steine E, Foreman R, Staerk J, Markoulaki S, Jaenisch R. 2008. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 26: 916-924.
45. Yalvac ME, Ramazanoglu M, Rizvanov AA, Sahin F, Bayrak OF, Salli U, Palotas A, Kose GT. 2010. Isolation and characterization of stem cells derived from human third molar tooth germs of young adults: Implications in neo-vascularization, osteo-, adipo-and neurogenesis. Pharmacogenomics J 10: 105-113.